Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1998-02-10
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
128898, 526304, 528421, 604 53, 604 20, 604 21, 604 96, 604269, 606198, 623 12, A61K 31335, A61M 2900
Patent
active
057169810
ABSTRACT:
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
REFERENCES:
patent: 4300244 (1981-11-01), Bokros
patent: 4531936 (1985-07-01), Gordon
patent: 4542025 (1985-09-01), Tice et al.
patent: 4580568 (1986-04-01), Gianturco
patent: 4733665 (1988-03-01), Palmaz
patent: 4739762 (1988-04-01), Palmaz
patent: 4776337 (1988-10-01), Palmaz
patent: 4800882 (1989-01-01), Gianturco
patent: 4824436 (1989-04-01), Wolinsky
patent: 4834755 (1989-05-01), Silvestrini et al.
patent: 4955878 (1990-09-01), See et al.
patent: 4960790 (1990-10-01), Stella et al.
patent: 4989601 (1991-02-01), Marchosky et al.
patent: 4990155 (1991-02-01), Wilkoff
patent: 5019090 (1991-05-01), Pinchuk
patent: 5049132 (1991-09-01), Shaffer et al.
patent: 5053048 (1991-10-01), Pinchuk
patent: 5059166 (1991-10-01), Fischell et al.
patent: 5059178 (1991-10-01), Ya
patent: 5059211 (1991-10-01), Stack et al.
patent: 5092841 (1992-03-01), Spears
patent: 5102417 (1992-04-01), Palmaz
patent: 5171217 (1992-12-01), March et al.
patent: 5171262 (1992-12-01), MacGregor
patent: 5176617 (1993-01-01), Fischell et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5234456 (1993-08-01), Silvestrini
patent: 5286254 (1994-02-01), Shapeland et al.
patent: 5292512 (1994-03-01), Schaefer et al.
patent: 5304121 (1994-04-01), Sahatjian
patent: 5314688 (1994-05-01), Kauffman et al.
patent: 5342348 (1994-08-01), Kaplan
patent: 5342621 (1994-08-01), Eury
patent: 5380299 (1995-01-01), Fearnot et al.
patent: 5383928 (1995-01-01), Scott et al.
patent: 5403858 (1995-04-01), Bastard et al.
patent: 5407683 (1995-04-01), Shively
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5419760 (1995-05-01), Narciso, Jr.
patent: 5439446 (1995-08-01), Barry
patent: 5439686 (1995-08-01), Desai et al.
patent: 5441745 (1995-08-01), Presant et al.
patent: 5447724 (1995-09-01), Helmus et al.
patent: 5449513 (1995-09-01), Yokoyama et al.
patent: 5457113 (1995-10-01), Cullinan et al.
patent: 5460817 (1995-10-01), Langley et al.
patent: 5462866 (1995-10-01), Wang
patent: 5464450 (1995-11-01), Buscemi et al.
patent: 5464650 (1995-11-01), Berg et al.
patent: 5473055 (1995-12-01), Mongelli et al.
Walter et al., "Interstitial Taxol Delivered from a Biodegradable Polymer Implant against Experimental Malignant Glioma," Cancer Research 54:2207-2212, 1994.
Bartoli et al., "In vitro and in vivo antitumoral activity of free, and encapsulated taxol," Journal of Microencapsulation 7(2): 191-197, 1990.
Bissett and Kaye, "Taxol and Taxotere--Current Status and Future Prospects," European Journal of Cancer 29A(9): 1228-1231, 1993.
De Scheerder et al., "Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries," Atherosclerosis 114: 105-114, 1995.
Floy et al., "Design of Biodegradable Polymer Systems for Controlled Release of Bioactive Agents," in El-Nokaly et al. (eds.), Polymeric Delivery Systems: Properties and Applications, American Chemical Society, Washington, D.C., 1993, pp. 154-167.
Holland et al., "Polymers for Biodegradable Medical Devices. 1. The Potential of Polyesters as Controlled Macromolecular Release Systems," Journal of Controlled Release 4: 155-180, 1986.
Jalil, R., "Biodegradable Poly(Lactic Acid) and Poly(Lactide-Co-Glycolide) Polymers in Sustained Drug Delivery," Drug Development and Industrial Pharmacy 16(16): 2353-2367, 1990.
Kohler and Goldspiel, "Evaluation of New Drugs. Paclitaxel (Taxol)," Pharmacotherapy 14(1): 3-34, 1994.
Kuhn, J., "Pharmacology and Pharmocokinetics of Paclitaxel," Annals of Pharmacotherapy 28: S15-S17, 1994.
Langer, R., "1994 Whitaker Lecture: Polymers for Drug Delivery and Tissue Engineering," Annals of Biomedical Engineering 23: 101-111, 1995.
Passl, W., "Synthetic Polymers in Modern Pharmacy," Prog. Polym. Sci. 14(5): 629-677, 1989.
Rowinsky et al., "Taxol: A Novel Investigational Antimicrotubule Agent," Journal of the National Cancer Institute 82: 1247-1259, 1990.
Sauro et al., "The Anti-Tumor Agent, Taxol, Attenuates Contractile Activity in Rat Aortic Smooth Muscle," Life Sciences 56(7): PL 157-161, 1995.
Schindler et al., "Biodegradable Polymers for Sustained Drug Delivery," Contemp. Top. Polym. Sci. 2: 251-89, 1977.
Sinko and Kohn, "Polymeric Drug Delivery Systems. An Overview," in El-Nokaly et al. (eds), Polymeric Delivery Systems: Properties and Applications, American Chemical Society, Washington D.C., 1993, pp. 18-41.
Sollott et al., "Taxol Inhibits Neointimal Smooth Muscle Cell Accumulation after Angioplasty in the Rat," Journal of Clinical Investigation 95: 1869-1876, 1995.
Sonnichsen and Relling, "Clinical Pharmacokinetics of Paclitaxel," Clin. Pharmacokinet. 27(4): 256-269, 1994.
Spencer and Faulds, "Paclitaxel. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in the Treatment of Cancer," Drugs 48(5): 794-847, 1994.
Vainionpaa et al., "Surgical Applications of Biodegradable Polymers in Human Tissues," Prog. Polym. Sci. 14: 679-716, 1989.
Yasumori et al., "Placement of Covered Self-Expanding Metallic Stents in the Common Bile Duct A Feasibility Study," Journal of Vascular and Interventional Radiology 4: 773-778, 1993.
Arsenault A. Larry
Hunter William L.
Machan Lindsay S.
Angiogenesis Technologies, Inc.
Kumar Shailendra
LandOfFree
Anti-angiogenic compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-angiogenic compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-angiogenic compositions and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2077723